-
公开(公告)号:US20180325898A1
公开(公告)日:2018-11-15
申请号:US16042206
申请日:2018-07-23
申请人: Paul S. Charifson , Kevin Michael Cottrell , Hongbo Deng , John P. Duffy , Huai Gao , Simon Giroux , Jeremy Green , Katrina Lee Jackson , Joseph M. Kennedy , David J. Lauffer , Mark Willem Ledeboer , Pan Li , John Patrick Maxwell , Mark A. Morris , Albert Charles Pierce , Nathan D. Waal , Jinwang Xu
发明人: Paul S. Charifson , Kevin Michael Cottrell , Hongbo Deng , John P. Duffy , Huai Gao , Simon Giroux , Jeremy Green , Katrina Lee Jackson , Joseph M. Kennedy , David J. Lauffer , Mark Willem Ledeboer , Pan Li , John Patrick Maxwell , Mark A. Morris , Albert Charles Pierce , Nathan D. Waal , Jinwang Xu
IPC分类号: A61K31/506 , A61K9/48 , C07D417/10 , A61K41/00 , C07D521/00 , C07D495/04 , C07D491/056 , C07D491/048 , C07D471/04 , C07D417/14 , C07D417/04 , C07D413/10 , C07D413/04 , C07D409/14 , C07D409/04 , C07D239/42 , C07D403/10 , C07D403/04 , C07D401/04 , C07D413/14 , C07D405/14 , C07D401/14 , A61K47/55 , A61K31/53 , A61K47/54 , A61K31/5377 , A61K9/20
CPC分类号: C07D401/14 , A61K9/20 , A61K9/48 , A61K31/506 , A61K31/53 , A61K31/5377 , A61K41/0038 , A61K47/545 , A61K47/55 , C07D239/42 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/04 , C07D413/10 , C07D413/14 , C07D417/04 , C07D417/10 , C07D417/14 , C07D471/04 , C07D491/048 , C07D491/056 , C07D495/04 , C07D521/00
摘要: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
-
公开(公告)号:US08343998B2
公开(公告)日:2013-01-01
申请号:US13099643
申请日:2011-05-03
申请人: David J. Lauffer , Pan Li , Dean Shannon , Jianglin Liang
发明人: David J. Lauffer , Pan Li , Dean Shannon , Jianglin Liang
IPC分类号: A61K31/4709 , A61P35/00
CPC分类号: C07D513/04
摘要: The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders.
摘要翻译: 本发明涉及可用于抑制c-Met蛋白激酶的化合物1。 本发明还提供包含化合物1的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。
-
公开(公告)号:US20100190774A1
公开(公告)日:2010-07-29
申请号:US12756301
申请日:2010-04-08
申请人: David J. Lauffer , Alexander Aronov , Pan Li , David D. Deininger , Kira McGinty , Dean Stamos , Jon H. Come , Michelle Stewart
发明人: David J. Lauffer , Alexander Aronov , Pan Li , David D. Deininger , Kira McGinty , Dean Stamos , Jon H. Come , Michelle Stewart
IPC分类号: A61K31/55 , C07D513/04 , A61K31/433 , A61P35/00 , A61P35/02 , A61K31/4439 , A61K31/5377 , A61K31/454 , C07D487/04 , A61K31/5025 , A61K31/551 , A61K31/549
CPC分类号: C07D498/04 , C07D487/04 , C07D513/04
摘要: The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proliferative disorders.
摘要翻译: 本发明提供了可用作c-Met酪氨酸激酶抑制剂的化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用该组合物治疗各种增殖性疾病的方法。
-
公开(公告)号:US08518938B2
公开(公告)日:2013-08-27
申请号:US13090563
申请日:2011-04-20
申请人: David J. Lauffer , Pan Li , Kira McGinty , Steven M. Ronkin , Qing Tang , Anne-Laure Grillot , Nathan D. Waal
发明人: David J. Lauffer , Pan Li , Kira McGinty , Steven M. Ronkin , Qing Tang , Anne-Laure Grillot , Nathan D. Waal
IPC分类号: A61K31/41 , A61K31/444 , A61K31/4545 , A61K31/5377 , C07D401/14 , C07D401/04 , C07D413/14 , C07D413/02
CPC分类号: C07D401/14 , C07D401/04 , C07D405/14 , C07D409/14 , C07D451/06
摘要: The present invention relates to compounds of formula I useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative disorders.
摘要翻译: 本发明涉及可用于抑制c-Met蛋白激酶的式I化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。
-
公开(公告)号:US20090048250A1
公开(公告)日:2009-02-19
申请号:US11841233
申请日:2007-08-20
申请人: Alex Aronov , David J. Lauffer , Huan Qiu Li , Ronald Charles Tomlinson , Pan Li
发明人: Alex Aronov , David J. Lauffer , Huan Qiu Li , Ronald Charles Tomlinson , Pan Li
IPC分类号: A61K31/5377 , C07D231/54 , A61K31/4152 , C07D471/04 , C07D413/04 , A61K31/437 , C07D403/02 , A61K31/53
CPC分类号: C07D403/14 , C07D407/14 , C07D409/14 , C07D471/04
摘要: The present invention provides compounds of formula I: These compounds, and pharmaceutically acceptable compositions thereof, are useful generally as kinase inhibitors, particularly as inhibitors of PRAK, GSK3, ERK2, CDK2, MK2, SRC, SYK, and Aurora-2. Accordingly, compounds and compositions of the invention are useful for treating or lessening the severity of a variety of disorders, including, but not limited to, heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases and viral diseases.
摘要翻译: 本发明提供式I化合物:这些化合物及其药学上可接受的组合物通常用作激酶抑制剂,特别是作为PRAK,GSK3,ERK2,CDK2,MK2,SRC,SYK和Aurora-2的抑制剂。 因此,本发明的化合物和组合物可用于治疗或减轻各种障碍的严重性,包括但不限于心脏病,糖尿病,阿尔茨海默氏病,免疫缺陷病症,炎性疾病,过敏性疾病,自身免疫疾病,破坏性 骨质疏松症,增殖性疾病,感染性疾病和病毒性疾病等骨骼疾病。
-
公开(公告)号:US07446199B2
公开(公告)日:2008-11-04
申请号:US10936470
申请日:2004-09-07
申请人: Alex Aronov , David J. Lauffer , Pan Li , Ronald C. Tomlinson
发明人: Alex Aronov , David J. Lauffer , Pan Li , Ronald C. Tomlinson
IPC分类号: C07D471/04 , C07D401/02
CPC分类号: C07D413/04 , C07D413/14 , C07D471/04 , C07D487/04
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供包含所述化合物的药学上可接受的组合物和使用该组合物治疗各种疾病,病症或病症的方法。
-
公开(公告)号:US07169800B2
公开(公告)日:2007-01-30
申请号:US10949027
申请日:2004-09-24
申请人: Alex Aronov , David J. Lauffer , Pan Li , Ronald C. Tomlinson
发明人: Alex Aronov , David J. Lauffer , Pan Li , Ronald C. Tomlinson
IPC分类号: A61K31/422 , C07D413/04
CPC分类号: C07D405/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D413/04 , C07D413/12 , C07D413/14 , C07D417/04
摘要: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides processes for preparing the compounds of this invention, pharmaceutically acceptable compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of various disorders.
摘要翻译: 本发明涉及可用于蛋白激酶抑制剂的化合物。 本发明还提供了制备本发明化合物的方法,包含本发明化合物的药学上可接受的组合物,以及使用该组合物治疗各种疾病的方法。
-
公开(公告)号:US09606886B2
公开(公告)日:2017-03-28
申请号:US13822812
申请日:2011-07-06
申请人: Pan Li
发明人: Pan Li
CPC分类号: G06F11/3065 , G06F11/3409 , G06F11/3466 , G06F11/3476 , G06F11/3495 , H04L43/062 , H04L43/0829 , H04L43/106 , H04W24/08 , H04W24/10
摘要: Disclosed are method and device for measuring system performance in real time. The method includes: the foreground receives a real-time measurement task comprising a measurement period parameter constructed by the background according to the concerned service data, with the quantity of the service data being lower than a preset value; the foreground extracts the current data corresponding to the real-time measurement task from a performance measurement cache area according to the measurement period parameter; the foreground acquires the real-time measurement data corresponding to the real-time measurement task according to the current data; and the foreground reports the real-time measurement data to the background. In the present invention, the background sends the concerned service data to the foreground by way of a real-time measurement task, and the foreground merely reports few service data.
-
公开(公告)号:US08481538B2
公开(公告)日:2013-07-09
申请号:US12441187
申请日:2007-09-18
申请人: Alexander Aronov , Jon Come , John Court , David Deininger , David Lauffer , Pan Li , Kira McGinty , Suganthini Nanthakumar , Dean Stamos , Kirk Tanner
发明人: Alexander Aronov , Jon Come , John Court , David Deininger , David Lauffer , Pan Li , Kira McGinty , Suganthini Nanthakumar , Dean Stamos , Kirk Tanner
IPC分类号: A61K31/5025 , C07D487/04 , A61P35/00 , A61P9/10
CPC分类号: C07D497/04 , C07D513/04
摘要: The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proliferative disorders.
摘要翻译: 本发明提供了可用作c-Met酪氨酸激酶抑制剂的化合物。 本发明还提供包含本发明化合物的药学上可接受的组合物和使用该组合物治疗各种增殖性疾病的方法。
-
公开(公告)号:US20110207774A1
公开(公告)日:2011-08-25
申请号:US13099643
申请日:2011-05-03
申请人: David Lauffer , Pan Li , Dean Shannon , Jianglin Liang
发明人: David Lauffer , Pan Li , Dean Shannon , Jianglin Liang
IPC分类号: A61K31/4709 , A61P35/00
CPC分类号: C07D513/04
摘要: The present invention relates to compound 1, which is useful in the inhibition of c-Met protein kinase. The invention also provides pharmaceutically acceptable compositions comprising Compound 1 and methods of using the compositions in the treatment of proliferative disorders.
摘要翻译: 本发明涉及可用于抑制c-Met蛋白激酶的化合物1。 本发明还提供包含化合物1的药学上可接受的组合物和使用该组合物治疗增殖性疾病的方法。
-
-
-
-
-
-
-
-
-